Introduction
Androgens are steroid hormones essential for proper male development, including the development of male external genitalia and virilization of the pubertal male. These androgen eects are mediated through the androgen receptor (AR) (Chang et al., 1988) , a member of the nuclear receptor superfamily. Nuclear receptors form a class of DNA-binding proteins which modulate transcription in a ligand-dependent manner (reviewed in Mangelsdorf et al., 1995; Mangelsdorf and Evans, 1995; Beato et al., 1995; Kastner et al., 1995; Thummel, 1995) . While the ligands for nuclear receptors are diverse, the receptors themselves are highly conserved in both structure and function. Most of the known nuclear receptors have an evolutionary conserved DNA-binding domain, required for sequence-speci®c DNA recognition, and a more varied ligand-binding domain giving nuclear receptors ligandspeci®c and ligand-dependent transcriptional activities (reviewed in Mangelsdorf et al., 1995) . Recent studies indicate that the transcriptional activity of nuclear receptors is dependent on a class of proteins collectively referred to as coactivators, proteins believed to bridge the nuclear receptors to the RNA polymerase II transcription machinery (reviewed in Gill and Tjian, 1992) . Biochemical assays and yeast twohybrid screens have identi®ed a number of receptor coactivators, including p140 and p160 (Kurokawa et al., 1995) , SRC-1 (Onate et al., 1995) , TIF-1 (Le Dourin et al., 1995) , TIF-2 (Voegel et al., 1996) , RIP-140 (Cavilles et al., 1995) , GRIP (Hong et al., 1996) , and CBP/p300 (Kamei et al., 1996; Chakravarti et al., 1996) . SRC-1, p160, TIF-2, and GRIP-1 are structurally related proteins which mediate the activity of the ligand-dependent AF-2 (activation function-2), a conserved motif within the distal C-terminus of many nuclear receptors (Durand et al., 1994) .
Based on homology within the DNA-binding domains, the AR is most closely related to the receptors for glucocorticoids (GR), progesterone (PR), and mineralocorticoids (MR). These receptors form a subfamily within the nuclear receptor superfamily that is capable of recognizing a common DNA sequence (Ham et al., 1988; Arriza et al., 1987) . While a number of genes have been shown to be activated by more than one receptor within this family, recent studies have identi®ed several genes that are activated speci®cally by AR (Claessens et al., 1996; Alder et al., 1992) or GR (Archer et al., 1994) . How gene-speci®c activation by AR or GR occurs is not presently understood, but several possible mechanisms have been proposed. These include promoter-speci®c elements¯anking and interacting with the hormone-response elements (HREs) that bind nuclear receptors (Scarlett and Robins 1995) , dierential chromatin eects on receptor activity (Archer et al., 1994) , or receptor interaction with distinct accessory factors (reviewed in Beato et al., 1995) . Nuclear receptors are known to interact with a variety of accessory factors. Interestingly, the interaction with the related coactivators SRC-1 and TIF-2 appears to be receptor-speci®c. While SRC-1 stimulates the transcriptional activity of GR and PR (Onate et al., 1995) , TIF-2 enhances transactivation by AR and PR, but not GR (Voegel et al., 1996) . An unrelated putative receptor coactivator, ARA70, was recently identi®ed that mediates only AR-induced transcription (Yeh and Chang, 1996) and thus may be partially responsible for androgen-speci®c responses.
We have previously published that another mediator of AR activity is the proto-oncoprotein c-Jun, which acts on AR without any apparent DNA binding (Bubulya et al., 1996; Shemshedini et al., 1991) . However, unlike SRC-1, TIF-2, or ARA70, all of which have only positive eects on nuclear receptors, cJun has been shown in several studies to negatively interact with many nuclear receptors, except AR (reviewed in Pfahl, 1993) . Our results indicate that the c-Jun positive eect on AR is independent of cellspeci®c and/or promoter-speci®c factors (Shemshedini et al., 1991; J Ober®eld and L Shemshedini, unpublished results) , making it distinct from the positive interaction between c-Jun and GR that has been seen only in several T cell lines (Maroder et al., 1993) . Furthermore, we have recently demonstrated that AR is stimulated by both exogenous and endogenous cJun, that c-Jun can relieve AR self-squelching, and that the c-Jun eect is primary (Bubulya et al., 1996) , all consistent with c-Jun serving a coactivator role in ARmediated transactivation.
c-Jun has been extensively characterized as a component of AP-1, a transcription factor that directly activates transcription of genes containing DNA sequences known as TREs (TPA-responsive elements) (reviewed in Angel and Karin, 1991) . The AP-1 family of transcription factors belong to the bZIP protein family (reviewed in Angel and Karin, 1991) and contains Junand Fos-related proteins. c-Jun binds to TREs either as a homodimer or heterodimer with either other Jun proteins or Fos proteins. Studies have identi®ed domains within c-Jun mediating dimerization, DNA binding, transactivation, and cellular transformation (reviewed in Angel and Karin, 1991) . More recent studies examining the transactivation properties of c-Jun have reported that this proto-oncogene activates AP-1-responsive promoters by interacting with coactivator proteins. It has been proposed that two of these proteins, CBP (Bannister et al., 1995) and P300 (Lee et al., 1996) , highly related coactivators important for both AP-1 and nuclear receptor activity, may mediate the mutual transcriptional interference between AP-1 and nuclear receptors (Kamei et al., 1996) .
While this ®nding with CBP/P300 may provide a potential molecular mechanism by which AP-1 and nuclear receptors negatively interact, it is unlikely to provide a better understanding of the c-Jun positive interaction with AR. As a way to better understand this c-Jun eect, we have begun studies to identify functional domains within c-Jun important for hAR activity. In this paper we describe results indicating that multiple regions of c-Jun are involved in mediating AR activity. Our results also suggest that c-Jun requires some accessory factor(s) to act on AR. Finally, we demonstrate that the c-Jun activity on AR is distinct from its activity on AP-1-responsive promoters.
Results

Experimental design
Our analysis of c-Jun domains important for mediating hAR-induced transcription was carried out using a series of c-Jun deletion and point mutations (Figure 1 ). These proteins were expressed from expression plasmids driven by either the rous sarcoma virus (RSV) promoter (M8, M9, M14, JunD194 ± 223, and JunD146 ± 221) or cytomegalovirus (CMV) promoter (JunD287 ± 331, JunD1 ± 245, JunA?D
265
In265, and cJun Ala63/73). These plamids were cotransfected in Cos-1 cells with a pSG5-derived hAR (Bubulya et al., 1996) and a reporter construct containing the Escherichia coli chloramphenicol acetyltransferase (CAT) gene under the control of the hAR-inducible mouse mammary tumor virus (MMTV) promoter (Shemshedini et al., 1991) .
The bZIP region of c-Jun is required, but not sucient, for mediating hAR-induced transactivation
The bZIP region of c-Jun, consisting of the basic region and leucine zipper, is required for dimerization and DNA binding (reviewed in Angel and Karin, 1991) . To determine if this region is also involved in cJun stimulation of hAR activity, several mutants of the leucine zipper and basic region were tested for their ability to support activation of MMTV-CAT ( Figure  2 ). As shown before in Cos cells (Bubulya et al., 1996) , transfected hAR has a weak DHT-dependent activity on MMTV-CAT ( Figure 2 ). As shown before in Cos cells (Bubulya et al., 1996) , transfected hAR has a weak DHT-dependent activity on MMTV-CAT (Figure 2a In265, has a one amino-acid substitution of glutamic acid for alanine at residue 265 and after a three amino-acid insertion of glutamines (Brown et al., 1996) c-Jun domains mediating androgen receptor activity SC Wise et al lane 2 with lanes 3 ± 5 and 6 ± 8). Since the JunD287 ± 331 mutant contains a large deletion (amino acids 287 ± 331), it may have lost its activity due to a conformation change on the protein rather than a deletion of a speci®cally required region, the leucine zipper.
To analyse this, we tested a series of leucine zipper point mutants. Mutants M8 and M9 (see Figure  1 ), which have a single leucine residue mutated to phenylalanine or histidine, respectively, have reduced but signi®cant activity on hAR ( Figure 2b , compare lanes 1 ± 3 with 4 ± 6 and 7 ± 9). Interestingly, the double mutant M14 (see Figure 1 ), which has lost the ability to dimerize , has little detectable activity (compare lanes 1 ± 3 with 10 ± 12).
To examine the role of the basic region, we tested the c-Jun mutant JunA?D
In265 (see Figure 1 ) having reduced basic region function (Brown et al., 1996) . This mutant was unable to support hAR-induced transactivation (Figure 2c , compare lane 2 with 3 ± 4 and 5 ± 6). Altogether, these results strongly suggest an essential role of the bZIP region in the c-Jun stimulation of hAR-induced transcription.
To examine a role for the c-Jun N-terminus in hAR transactivation, we tested JunD1 ± 245, a c-Jun mutant lacking amino acids 1 ± 245 (see Figure 1 ). This mutant is missing all known c-Jun transactivation domains and thus is transcriptionally inactive (S Wise and M Birrer, unpublished results), Coexpression of JunD1 ± 245 had no detectable eect on hAR-induced transcription (Figure 3 , compare lane 2 with lanes 5 and 6), indicating that some portion of the c-Jun N-terminus is required for stimulating hAR activity.
JunB and JunD have dierent eects on hAR
JunB and JunD share high homology with c-Jun in the bZIP region, but are less conserved in their N-terminal sequences (Angel et al., 1988) , and thus have dierent activities ). Since our results above suggest that the c-Jun N terminus is important in stimulation of hAR activity, we decided to analyse JunB and JunD for supporting hAR-induced transcription. Transfecting increasing amounts of expression plasmid for JunB resulted in a dose-dependent increase v-Jun is unable to mediate hAR-induced transactivation c-Jun was originally identi®ed as the cellular component of a retrovirally transduced oncogene, vJun (Maki et al., 1987) . c-Jun and v-Jun share signi®cant sequence homology and are both capable of activating transcription . Therefore, it was important to determine if v-Jun had the same eect as c-Jun on hAR-induced transcription. As shown previously , c-Jun and v-Jun are equally active in Cos cells on the AP-1-responsive reporter plasmid, TREtk-CAT (Figure 5b , compare lanes 2 ± 4 with 5 ± 7). In contrast, v-Jun was markedly less active than c-Jun on hAR-induced transcription (Figure 5c , compare lanes 6 ± 8 with 3 ± 5). Comparison of the amino-acid sequence reveals v-Jun and c-Jun to exhibit significantly variability in the N-terminal half, including deletion of the 27-amino acid`delta region' from the N terminus of v-Jun , whereas the Cterminal half, containing the bZIP region, is almost identical between these two proteins (Maki et al., 1987) . Consequently, chimeras of c-Jun and v-Jun (see 
A novel domain within c-Jun is required for mediating hAR-induced transactivation
Our results with v-Jun suggest stimulation of hAR transcriptional activity is dependent on a region within the N-terminal half of c-Jun. Comparison between cJun and v-Jun reveals that the highest degree of variability in amino-acid sequence is found in the region of v-Jun equivalent to c-Jun amino acids 140 ± 215. In order to determine if this region accounts for the speci®c eect of c-Jun on hAR, internal deletion mutants within this region were tested. c-Jun mutant JunD194 ± 223 (see Figure 1) has an activity on hAR as strong as does wild-type c-Jun (Figure 6 , compare lanes 6 ± 8 with 3 ± 5). However, removal of an additional 48 amino acids on the N-terminal side, generating JunD146 ± 221, greatly reduces the activity (Figure 6, lanes 9 ± 11) . These results suggest amino 
Transactivation and enhancement of hAR appear to be two distinct actions of c-Jun
We have previously shown that hAR can undergo transcriptional self-squelching and exogenous c-Jun is able to relieve this squelching (Bubulya et al., 1996) . Interestingly, c-Jun activity on hAR can also undergo squelching. Upon cotransfection of increasing amounts of c-Jun with a ®xed amount of hAR, a bell-shaped curve of activity was observed on MMMTV-CAT with maximal activity at 0.1 mg of c-Jun (Figure 7a , lanes 3 ± 7). In contrast, c-Jun activity on the AP-1-responsive reporter TRE-tk-CAT showed maximal activity at a higher concentration of 1 ± 3 mg of c-Jun (Figure 7a , lanes 9 ± 13). The level of expression of transfected c-Jun in these two experiments did not signi®cantly vary, as measured by Western blot analysis (Figure 7b , compare lanes 2 ± 6 with 8 ± 12). These results suggest that c-Jun's role in hAR transactivation is distinct from its direct action in AP-1 transactivation and may involve limiting factors in Cos cells that are dierent from those required for activation of an AP-1-responsive promoter.
In order to further distinguish between c-Jun's transactivation ability on an AP-1 reporter and cJun's distinct ability to stimulate hAR transactivation, we looked at a c-Jun mutant in which two key phosphorylation residues in the N terminus have been mutated. The serines at amino acid residues 63 and 73, known to be phosphorylated by JNK (Jun N-terminal kinase) (Pulverer et al., 1991; Smeal et al., 1991) , have been substituted by alanines in the mutant c-Jun Ala63/73. As seen previously , this mutant is weakly active on an AP-1 reporter when compared to wild type c-Jun (Figure 8 , compared lanes 7 or 6 with 5). However, upon cotransfection with hAR on MMTV-CAT, c-Jun Ala63/73 stimulates hAR as well as wild type c-Jun (Figure 8 , compare lanes 3 or 4 with 2). This suggests that the phosphorylation of cJun residues 63 and 73, known to be critical in transactivation, do not appear to play a signi®cant role in c-Jun's activity on hAR, providing further evidence for two distinct mechanisms of c-Jun action on transcription. 
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Figure 6 A novel domain in cJun is involved in cJun stimulation of hAR activity. Cos cells were transfected with 1 mg of the MMTV-CAT reporter and 2 mg of hAR. Increasing amounts (0.05, 0.1 or 0.5 mg) of wild type c-Jun/RSV (lanes 3 ± 5) or the internal deletion mutants, JunD194 ± 223 (lanes 6 ± 8) and JunD146 ± 221 (lanes 9 ± 11) were added as indicated. 100 nM DHT was used in all cases c-Jun domains mediating androgen receptor activity SC Wise et al
Discussion
Previous results from our lab show that c-Jun can act as a mediator of hAR-induced transcription (Bubulya et al., 1996) . This eect appears to be primary and can be seen with both exogenous and endogenous c-Jun (Bubulya et al., 1996) . In this study, we have analysed c-Jun functional domains important for this novel activity of c-Jun and our results indicate that multiple regions of c-Jun are involved. The transactivation properties of c-Jun are well characterized. It is able to form homodimers with itself or a variety of heterodimers with either other Jun family members or Fos family members (reviewed in Angel and Karin, 1991) . Collectively, these homo-and heterodimers form the transcription factor AP-1. Dimerization between these two families of proteins is mediated via the leucine zipper, a portion of the conserved bZIP region that is also involved in sequence-speci®c DNA binding (reviewed in Angel and Karin, 1991) . Interestingly, the results in this study indicate that a functional bZIP region of c-Jun is essential for induction of hAR transcriptional activity, since mutations within both the leucine zipper and basic region compromise c-Jun's activity. Our data with the leucine zipper mutants suggest that dimerization of c-Jun is necessary for its activity on hAR. However, if dimerization is indeed necessary, the speci®c activity on hAR depends on the c-Jun dimerization partner. Our previous results have shown that the bZIP proteins c-Fos (Shemshedini et al., 1991; Bubulya et al., 1996) and GCN4 (L Burmeister and L Shemshedini, unpublished results) negatively regulate c-Jun's activity on hAR. Recent results showing a protein-protein interaction between the c-Jun bZIP region and the general transcription factors TBP and TFIIB (Franklin et al., 1995) or TFIIE-34 and TFIIF (Martin et al., 1996) suggest another possible role for the c-Jun bZIP in hAR transactivation. Perhaps interaction between c-Jun and these general transcription factors is necessary for stimulation of hAR activity. If this is the case, then it is possible that cJun monomers might be acting on hAR. Indeed, a derivative of c-Jun has been constructed which is able to activate transcription in vivo as a monomeric protein (Deng and Karin, 1992) .
While the bZIP region of c-Jun is necessary for cJun action on hAR, it is not sucient. Deletion of the entire amino-terminus (amino acids 1 ± 245) in JunD1 ± 245, a mutant retaining the bZIP region and carboxy terminus, resulted in complete loss of c-Jun activity on hAR. These results strongly argue that some part of the c-Jun amino terminus is required. This region has several activation functions (AFs) (Bohmann and Tijan, 1989; Angel et al., 1989) and phosphorylation sites important for the functions of some of these c-Jun AFs (reviewed in Karin, 1995) . A series of smaller cJun N-terminal truncations, from amino acids 3 ± 80 to 3 ± 198, all severely aected c-Jun's activity on hAR 3, 6) or the transactivation mutant, cJun Ala63/73 (lanes 4, 7) were added as indicated. Lanes 2 ± 4 were exposed to 100 nM DHT (S Wise and L Shemshedini, unpublished results), suggesting that the entire amino terminus is important for hAR activity. It is equally likely that multiple c-Jun AFs are necessary for action on hAR. Interestingly, one of these N-terminal truncations, TAM67, has previously been shown to be a dominant negative of c-Jun activity (Brown et al., 1994) . While its activity on hAR was signi®cantly lower than that of wild type c-Jun, TAM67 did have a weakly positive activity (S Wise and L Shemshedini, unpublished results), suggesting that it may not be acting as a dominant negative in hAR-induced transcription.
Amino acids 194 ± 223 do not appear to play a signi®cant role, since deletion of this region from c-Jun does not aect its ability to support hAR transcriptional activity. However, a larger truncation to include amino acids 146 ± 221 greatly compromises c-Jun's activity. Interestingly, a similar c-Jun mutant has previouly been shown to be de®cient in interacting with the estrogen receptor (ER) (Doucas et al., 1991) . However, the c-Jun interaction with ER is negative (Doucas et al., 1991) . These results together imply that a conserved region of c-Jun, within amino acids 146 ± 221, is involved in both inhibiting and activating nuclear receptors. Since this region has no known AFs, it may be acting as a protein-protein interaction domain with either nuclear receptors directly or proteins mediating c-Jun action on nuclear receptors. One possible mediator is CBP/p300, a co-integrator of multiple signalling pathways, including those of nuclear receptors and AP-1 (Kamei et al., 1996) . It was recently shown that p300 interacts with c-Jun amino acids 96 ± 193 (Lee et al., 1996) , which overlaps part of the c-Jun region important for hAR transactivation and ER repression. While this hypothesis is appealing, we have yet to obtain any results suggesting a CBP/ p300 involvement in the hAR-c-Jun interaction (L Burmeister, A Bubulya and L Shemshedini, unpublished results) .
A requirement for additional factors in the c-Jun stimulation of hAR activity is strongly suggested by other data. Our ®nding that hAR-induced transactivation can be squelched by high amounts of c-Jun suggests that c-Jun is titrating some limiting factor(s) necessary for AR activation. Neither CBP/p300 nor TIF-2 (Voegel et al., 1996) is able to relieve this squelching (A Bubulya and L Shemshedini, unpublished results) . Other possible candidates are the previously identi®ed AR coactivators, SRC-1 (Onate et al., 1995) and ARA70 (Yeh and Chang, 1996) . In view of the close relatedness between SRC-1 and TIF-2, it is unlikely that SRC-1 is involved in the AR-c-Jun interaction. Another candidate is JAB1, a recently identi®ed protein found to mediate c-Jun transactivation of AP-1-responsive promoters. Interestingly, the JAB1 eect, like the c-Jun eect on AR, does not depend on phosphorylation of c-Jun residues serines 63 and 73 (Claret et al., 1996) . Thus, it is conceivable that JAB1 may play a role in the c-Jun-AR interaction.
We have previously reported that c-Jun can interact with the DNA-binding domain of hAR in a mammalian one-hybrid assay (Bubulya et al., 1996) . Further work, including studies on in vitro proteinprotein interactions and DNA binding with Cos cellexpressed hAR and c-Jun, to con®rm this interaction have failed (A Bubulya and L Shemshedini, unpublished results). Recently, Sato et al. (1997) have succeeded in co-immunoprecipitating hAR with c-Jun or c-Fos from the prostate cancer line LNCaP. These results together suggest that the hAR-c-Jun physical interaction is a weak one whose strength may depend on cell-speci®c factors. However, the positive eect of c-Jun on hAR activity does not appear to be dependent on cell-speci®c factors, since we have seen it in all cell lines that we have tested, including LNCaP cells (A Bubulya and L Shemshedini, unpublished results). In contrast, c-Jun's activity on GR can be either negative or positive, depending on the cell type (Maroder et al., 1993) . This dierence between AR and GR may be due to the high variability that exists between these two proteins in their transcriptional activation functions. The GR relies mainly on its C-terminal AF-2 for transcriptional activity, which has been shown in several nuclear receptors to be inhibited by c-Jun (reviewed in Pfahl, 1993) . In contrast, the AR has much stronger N-terminal AF-1 than AF-2 (Jenster et al., 1995) . We have recently determined that the c-Jun positive eect on hAR is targeted to its AF-1 (A Bubulya et al., unpublished results). Thus, it is conceivable that c-Jun can repress AF-2 activity and enhance AF-1 activity. If this is the case, then the sole example of a c-Jun positive eect on GR activity that has been reported in T cells (Maroder et al., 1993) may be due to the GR AF-1 being stronger than its AF-2 in these cells.
The transcriptional activity of c-Jun, either as a homodimer or heterodimer with c-Fos, on AP-1-responsive promoters depends on phosphorylation of Ser residues 63 and 73 by JNK (Pulverer et al., 1991; Smeal et al., 1991) . This phosphorylation event is the end-product of a Ras-dependent protein kinase pathway in response to growth factors (Minden et al., 1994) . Our ®nding that phosphorylation of these two serines is not required for c-Jun enhancement of ARinduced transactivation suggests a JNK-and Rasindependent mechanism by which c-Jun can modulate transcription. The prevalence of this potential mechanism is unknown, but it is interesting to note that c-Jun has an interaction with the Ets transcription factor, ERM (Nakae et al., 1995) , that is similar to its interaction with AR. Future work will allow us to determine how similar these c-Jun interactions are and whether a common mechanism is involved.
Materials and methods
Plasmids
hAR was expressed from the mammalian expression plasmid pSG5. Wild type c-Jun and mutants cloned into either RSV-or CMV-based eukaryotic expression vectors have been previously described: c-Jun/CMV (Brown et al., 1996) ; c-Jun/RSV ; JunD287 ± 331 (Alani et al., 1991) ; the leucine zipper point mutants, M8, M9 and M14, ; internal deletion mutants, JunD194 ± 223 and JunD146 ± 221 ; JunA?D 265 In265 (Brown et al., 1996) ; c-Jun/v-Jun chimeras (Oehler et al., 1993) ; and cJun Ala63/73 (Smeal et al., 1991) . JunB (Schutte et al., 1989) and JunD (Ryder et al., 1989) have been previously described. JunD1 ± 245 was constructed by using the polymerase chain reaction (PCR) to amplify c-Jun amino acids 246 ± 331. The 5' oligonucleo-tide used contained a¯anking EcoRI site with an in frame ATG. This PCR fragment was cloned into the EcoRI site of the RSV-based vector .
The reporter plasmids have the gene for chloramphenicol acetyl transferase (CAT) driven by either the AR-inducible MMTV or the AP-1-inducible TRE-tk promoters (Shemshedini et al., 1991) . Transfection eciency was standardized by measuring the b-galactosidase (b-gal) activity, originating from the co-transfected plasmid pCH110.
Cell transfections and CAT assays
Cos cells were grown in DMEM (Sigma) and supplemented with 5% fetal bovine serum (FBS) (Hyclone Laboratories). Cells were grown in 60 mm dishes and transiently transfected using the calcium phosphate precipitation method (Gronemeyer et al., 1987) . The human AR (hAR) was activated by the addition of 100 nM of dihydroxytestosterone (DHT) (Sigma). CAT assays were performed and standardized according to the measured b-gal activity as previously described (Gronemeyer et al., 1987) . For all transfections, we used dierent amounts of expression plasmid, 1 mg of reporter plasmid (either MMTV-CAT or TRE-tk-CAT), 2 mg of pCH110 and enough carrier DNA (Bluescript) to bring the ®nal plasmid amount to 9 mg per dish. Note that all transfections were done at least three times, and the results presented in this paper are representative.
SDS ± PAGE and Western blot
To prepare cell extracts for Western blot analysis, the pellets from transfected cells remaining after extraction for b-gal and CAT assays were boiled for 5 ± 10 min in SDSSample Buer (63 mM Tris, pH 6.8; 20% glycerol; 2% SDS; 5% b-mercaptoethanol). The amount of extract used was standardized according to b-gal activity. Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE) and were electrotransferred onto nitrocellulose (Micron Separations Inc.). After blocking with nonfat dry milk, the nitrocellulose blots were probed with anti-cJun antibody c-Jun/AP-1(sc #44) (Santa Cruz Biotechnology). The blots were developed using the chemiluminescence detection kit from Amersham.
